로딩 중…
지수 로딩 중…
Celcuity Inc.
CELC· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$87.72+1.55%
2026-08-03
Financials
Valuation Metrics
Celcuity Inc.'s Market Cap is $4.28B. At end of 2025 it was $5.24B. Ranked #1514 of 3,111 in US market (top 49%), #526 of 1,445 on NASDAQ (top 36%), #86 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 32%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $4.28B | US#1,514/3,111 Sec#86/269 |
| Revenue | $0.00 | US#2,980/3,111 Sec#205/269 |
| Net Income | $-193M | US—/3,111 Sec—/269 |
| Total Assets | $410M | US#2,826/3,111 Sec#184/269 |
| Net Assets | $54M | US#2,942/3,111 Sec#243/269 |
| Value | ||
| P/B | 79.92x | US#2,957/3,111 Sec#257/269 |
| FCF Yield | -4.04% | US—/3,111 Sec—/269 |
| Profitability | ||
| ROA | -47.03% | US#2,967/3,111 Sec#212/269 |
| Financial Health | ||
| Debt Ratio | 666.30% | US#2,524/3,111 Sec#239/269 |
| Total Debt | $196M | US#2,228/3,111 Sec#97/269 |
| FCF | $-173M | US#2,715/3,111 Sec#204/269 |
| Cash | $145M | US#1,957/3,111 Sec#148/269 |
| Current Ratio | 12.31x | US#201/3,111 Sec#69/269 |
| Performance | ||
| 1Y Return | 119.79% | US#217/3,111 Sec#66/269 |
| 1M Return | -18.74% | US#2,776/3,111 Sec#228/269 |
| From 52W High | -41.91% | US#2,567/3,111 Sec#202/269 |
| 1Y MDD | -43.25% | US#2,114/3,111 Sec#157/269 |
| Trading | ||
| Volume | 543,947 shares | US#1,863/3,111 Sec#181/269 |
| Trading Value | $47M | US#1,261/3,111 Sec#79/269 |
| Per Share | ||
| EPS | $-3.37 | US—/3,111 Sec—/269 |
| BPS | $1.91 | US#2,527/3,111 Sec#181/269 |